Symbols / SLSN Stock $1.50 +11.11% Solesence, Inc.

Consumer Defensive • Household & Personal Products • United States • NCM
SLSN (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Consumer Defensive
Industry Household & Personal Products
CEO Mr. Kevin Cureton
Exch · Country NCM · United States
Market Cap 105.95M
Enterprise Value 118.39M
Income 1.79M
Sales 62.06M
FCF (ttm) -11.55M
Book/sh 0.25
Cash/sh 0.02
Employees 115
Insider 10d —
IPO Nov 26, 1997
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E 75.00
Forward P/E —
PEG —
P/S 1.71
P/B 6.00
P/C —
EV/EBITDA 47.95
EV/Sales 1.91
Quick Ratio 0.58
Current Ratio 2.07
Debt/Eq 137.91
LT Debt/Eq —
EPS (ttm) 0.02
EPS next Y —
EPS Growth —
Revenue Growth -0.70%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-05-12
Earnings (prior) 2009-03-26
ROA 1.96%
ROE 10.99%
ROIC —
Gross Margin 25.88%
Oper. Margin 1.49%
Profit Margin 2.88%
Shs Outstand 70.63M
Shs Float 18.32M
Insider Own 73.11%
Instit Own 6.40%
Short Float 4.14%
Short Ratio 19.22
Short Interest 846.50K
52W High 5.63
vs 52W High -73.36%
52W Low 0.78
vs 52W Low 92.31%
Beta 1.30
Impl. Vol. —
Rel Volume 3.11
Avg Volume 35.39K
Volume 109.89K
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom None
Prev Close $1.35
Price $1.50
Change 11.11%
About

Solesence, Inc., a science-driven company, provides engineered materials, formulation development, and commercial manufacturing services in the United States. The company engages in the manufacture and supply of surface engineered zinc oxide and titanium dioxide ingredients. It also provides skin care formulations with mineral-based UV protection enabled by proprietary active pharmaceutical ingredients; and skin health products, such as sunscreens and daily care products. The company sells products in various markets, including medical diagnostics, architectural coatings, industrial coating applications, abrasion-resistant additives, and plastics additives applications. It serves skin health, beauty, and wellness sectors. The company was formerly known as Nanophase Technologies Corporation and changed its name to Solesence, Inc. in March 2025. Solesence, Inc. was incorporated in 1989 and is headquartered in Romeoville, Illinois.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$1.50
Latest analyst target
3. DCF / Fair value
$-2.94
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$1.50
Low
—
High
—
Mean
—
News
RSS: Latest SLSN news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-12-24 WHITMORE R JANET Director — 2,500 $1.91 $4,787
2025-11-19 WHITMORE R JANET Director — 35,056 $1.73 $63,274
2025-06-06 CURETON KEVIN Chief Operating Officer — 43,500 $3.80 $166,051
2025-06-06 CURETON KEVIN Chief Operating Officer — 43,500 $0.42 $18,270
2025-05-29 WHITMORE BRADFORD T Beneficial Owner of more than 10% of a Class of Security — 6,689,000 $4.20 $28,093,800
2025-05-29 WHITMORE BRADFORD T Beneficial Owner of more than 10% of a Class of Security — 6,689,000 $4.20 $28,093,800
2024-10-29 WHITMORE R JANET Director — 45,333 $1.10 $58,346
2024-10-29 WHITMORE R JANET Director — 2,000 $0.90 $1,800
2024-09-24 WHITMORE R JANET Director — 49,900 $1.55 $79,550
2024-09-24 JANKOWSKI JESS Chief Executive Officer — 81,000 $0.44 $35,964
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
62.06
+18.56%
52.35
+40.35%
37.30
-0.05%
37.32
Operating Revenue
61.79
+19.09%
51.89
+41.62%
36.64
-0.25%
36.73
Cost Of Revenue
46.00
+27.22%
36.16
+22.69%
29.47
+1.78%
28.96
Reconciled Cost Of Revenue
46.00
+27.22%
36.16
+22.69%
29.47
+1.78%
28.96
Gross Profit
16.06
-0.77%
16.19
+106.88%
7.83
-6.40%
8.36
Operating Expense
14.49
+31.07%
11.06
-2.77%
11.37
+7.09%
10.62
Research And Development
4.09
+6.59%
3.84
+0.00%
3.84
+26.34%
3.04
Selling General And Administration
10.40
+44.08%
7.22
-4.18%
7.53
-0.62%
7.58
Total Expenses
60.49
+28.12%
47.22
+15.60%
40.84
+3.20%
39.58
Operating Income
1.57
-69.37%
5.13
+244.73%
-3.55
-57.04%
-2.26
Total Operating Income As Reported
1.57
-69.37%
5.13
+244.73%
-3.55
-57.04%
-2.26
EBITDA
3.69
-39.09%
6.06
+316.12%
-2.80
-65.82%
-1.69
Normalized EBITDA
3.69
-39.09%
6.06
+316.12%
-2.80
-65.82%
-1.69
Reconciled Depreciation
0.90
-3.34%
0.93
+25.07%
0.74
+30.86%
0.57
EBIT
2.79
-45.56%
5.13
+244.73%
-3.55
-57.04%
-2.26
Net Income
1.79
-57.73%
4.24
+196.47%
-4.39
-67.37%
-2.62
Pretax Income
1.86
-58.25%
4.46
+201.78%
-4.38
-66.06%
-2.64
Net Non Operating Interest Income Expense
-0.93
-38.96%
-0.67
+20.05%
-0.84
-119.37%
-0.38
Interest Expense Non Operating
0.93
+38.96%
0.67
-20.05%
0.84
+119.37%
0.38
Net Interest Income
-0.93
-38.96%
-0.67
+20.05%
-0.84
-119.37%
-0.38
Interest Expense
0.93
+38.96%
0.67
-20.05%
0.84
+119.37%
0.38
Other Income Expense
1.22
—
—
—
Other Non Operating Income Expenses
1.22
—
—
—
Tax Provision
0.07
-67.84%
0.23
+3683.33%
0.01
+135.29%
-0.02
Tax Rate For Calcs
0.00
-22.98%
0.00
-75.77%
0.00
+3161.38%
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
1.79
-57.73%
4.24
+196.47%
-4.39
-67.37%
-2.62
Net Income From Continuing Operation Net Minority Interest
1.79
-57.73%
4.24
+196.47%
-4.39
-67.37%
-2.62
Net Income From Continuing And Discontinued Operation
1.79
-57.73%
4.24
+196.47%
-4.39
-67.37%
-2.62
Net Income Continuous Operations
1.79
-57.73%
4.24
+196.47%
-4.39
-67.37%
-2.62
Normalized Income
1.79
-57.73%
4.24
+196.47%
-4.39
-67.37%
-2.62
Diluted EPS
0.02
-71.43%
0.07
+177.78%
-0.09
-80.00%
-0.05
Basic EPS
0.03
-57.14%
0.07
+177.78%
-0.09
-80.00%
-0.05
Basic Average Shares
70.34
+12.82%
62.35
+25.82%
49.56
+0.89%
49.12
Diluted Average Shares
72.58
+11.61%
65.03
+31.22%
49.56
+0.89%
49.12
Diluted NI Availto Com Stockholders
1.79
-57.73%
4.24
+196.47%
-4.39
-67.37%
-2.62
Line Item Trend 2023-12-31
Total Assets
32.88
Current Assets
16.30
Cash Cash Equivalents And Short Term Investments
1.72
Cash And Cash Equivalents
1.72
Cash Financial
1.72
Receivables
3.47
Accounts Receivable
3.47
Gross Accounts Receivable
3.69
Allowance For Doubtful Accounts Receivable
-0.23
Inventory
10.03
Raw Materials
8.52
Finished Goods
2.18
Prepaid Assets
—
Other Current Assets
1.08
Total Non Current Assets
16.58
Gross PPE
38.47
Accumulated Depreciation
-21.90
Properties
0.00
Machinery Furniture Equipment
24.48
Construction In Progress
0.93
Other Properties
7.91
Leases
5.16
Other Non Current Assets
0.00
Total Liabilities Net Minority Interest
30.98
Current Liabilities
15.59
Payables And Accrued Expenses
7.13
Payables
6.39
Accounts Payable
6.39
Other Payable
—
Current Accrued Expenses
0.74
Current Debt And Capital Lease Obligation
6.11
Current Debt
4.81
Other Current Borrowings
2.00
Current Capital Lease Obligation
1.30
Current Deferred Liabilities
2.35
Current Deferred Revenue
2.35
Total Non Current Liabilities Net Minority Interest
15.39
Long Term Debt And Capital Lease Obligation
15.15
Long Term Debt
6.00
Long Term Capital Lease Obligation
9.15
Long Term Provisions
0.24
Non Current Deferred Liabilities
0.00
Non Current Deferred Revenue
0.00
Stockholders Equity
1.90
Common Stock Equity
1.90
Capital Stock
0.50
Common Stock
0.50
Preferred Stock
0.00
Share Issued
49.63
Ordinary Shares Number
49.63
Treasury Shares Number
0.00
Additional Paid In Capital
106.07
Retained Earnings
-104.66
Total Equity Gross Minority Interest
1.90
Total Capitalization
7.90
Working Capital
0.71
Invested Capital
12.71
Total Debt
21.26
Net Debt
9.09
Capital Lease Obligations
10.45
Net Tangible Assets
1.90
Tangible Book Value
1.90
Inventories Adjustments Allowances
-0.68
Line Of Credit
2.81
Other Inventories
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-8.57
-534.65%
1.97
+198.26%
-2.01
-21.58%
-1.65
Cash Flow From Continuing Operating Activities
-8.57
-534.65%
1.97
+198.26%
-2.01
-21.58%
-1.65
Net Income From Continuing Operations
1.79
-57.73%
4.24
+196.47%
-4.39
-67.37%
-2.62
Depreciation Amortization Depletion
0.90
-3.34%
0.93
+25.07%
0.74
+30.86%
0.57
Depreciation
—
0.93
+25.07%
0.74
+30.86%
0.57
Depreciation And Amortization
0.90
-3.34%
0.93
+25.07%
0.74
+30.86%
0.57
Other Non Cash Items
—
—
—
—
Stock Based Compensation
0.57
-20.69%
0.72
-6.21%
0.77
+23.68%
0.62
Operating Gains Losses
—
—
—
—
Change In Working Capital
-11.83
-201.99%
-3.92
-550.75%
0.87
+496.80%
-0.22
Change In Receivables
-1.97
-40.30%
-1.40
-231.77%
1.06
+233.50%
-0.80
Changes In Account Receivables
-1.97
-40.30%
-1.40
-231.77%
1.06
+233.50%
-0.80
Change In Inventory
1.76
+117.16%
-10.24
-758.72%
-1.19
+56.56%
-2.74
Change In Prepaid Assets
0.66
+138.47%
-1.72
-696.76%
-0.22
-590.91%
0.04
Change In Payables And Accrued Expense
-7.40
-215.84%
6.39
+1084.13%
-0.65
-134.10%
1.90
Change In Accrued Expense
-2.02
-150.70%
3.99
+2831.51%
-0.15
-289.61%
0.08
Change In Payable
-5.38
-324.14%
2.40
+576.94%
-0.50
-127.55%
1.83
Change In Account Payable
-5.38
-324.14%
2.40
+576.94%
-0.50
-127.55%
1.83
Change In Other Working Capital
-4.88
-259.77%
3.06
+64.07%
1.86
+35.42%
1.38
Investing Cash Flow
-2.14
+52.98%
-4.56
-333.68%
-1.05
+62.77%
-2.82
Cash Flow From Continuing Investing Activities
-2.14
+52.98%
-4.56
-333.68%
-1.05
+62.77%
-2.82
Net PPE Purchase And Sale
-2.14
+52.98%
-4.56
-333.68%
-1.05
+62.77%
-2.82
Purchase Of PPE
-2.14
+52.98%
-4.56
-333.68%
-1.05
+62.77%
-2.82
Capital Expenditure
-2.14
+52.98%
-4.56
-333.68%
-1.05
+62.77%
-2.82
Financing Cash Flow
10.59
+365.66%
2.27
-12.30%
2.59
-56.80%
6.00
Cash Flow From Continuing Financing Activities
10.59
+365.66%
2.27
-12.30%
2.59
-56.80%
6.00
Net Issuance Payments Of Debt
10.27
+276.70%
-5.81
-330.56%
2.52
-56.70%
5.82
Issuance Of Debt
10.27
+5033.00%
0.20
-96.25%
5.34
-10.00%
5.93
Repayment Of Debt
0.00
+100.00%
-6.01
-113.27%
-2.82
-2438.74%
-0.11
Long Term Debt Issuance
5.50
+2650.00%
0.20
-96.25%
5.34
-10.00%
5.93
Long Term Debt Payments
0.00
+100.00%
-1.20
+10.85%
-1.35
-1112.61%
-0.11
Net Long Term Debt Issuance
5.50
+650.00%
-1.00
-125.05%
3.99
-31.41%
5.82
Short Term Debt Issuance
4.77
0.00
—
35.52
Short Term Debt Payments
0.00
+100.00%
-4.81
-226.77%
-1.47
+95.03%
-29.59
Net Short Term Debt Issuance
4.77
+199.09%
-4.81
-226.77%
-1.47
-124.82%
5.93
Proceeds From Stock Option Exercised
0.32
-84.50%
2.08
+2754.79%
0.07
-59.89%
0.18
Changes In Cash
-0.12
+61.34%
-0.31
+32.54%
-0.46
-130.35%
1.53
Beginning Cash Position
1.41
-18.18%
1.72
-21.23%
2.19
+232.72%
0.66
End Cash Position
1.29
-8.59%
1.41
-18.18%
1.72
-21.23%
2.19
Free Cash Flow
-10.71
-313.99%
-2.59
+15.37%
-3.06
+31.66%
-4.47
Interest Paid Supplemental Data
1.02
+60.44%
0.64
-15.29%
0.75
+125.83%
0.33
Issuance Of Capital Stock
0.00
-100.00%
6.00
0.00
—
Net Preferred Stock Issuance
0.00
-100.00%
6.00
0.00
—
Preferred Stock Issuance
0.00
-100.00%
6.00
0.00
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category